EdgarLookup

Nutanix, Inc. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Nutanix, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Financials Insiders
7.4%
Profit Margin
Net income ÷ revenue
5.7%
Return on Assets
Net income ÷ assets
-5.73x
Debt-to-Equity
Total liabilities ÷ equity
+18.1%
Revenue Growth
Year over year

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Jul 31, 2025 $2.54B Sep 24, 2025
FY2025 Jul 31, 2024 $2.15B Sep 24, 2025
FY2025 Jul 31, 2023 $1.86B Sep 24, 2025
FY2024 Jul 31, 2022 $1.58B Sep 19, 2024
FY2023 Jul 31, 2021 $1.39B Sep 21, 2023
FY2020 Jul 31, 2020 $327.87M Sep 23, 2020
FY2020 Apr 30, 2020 $318.27M Sep 23, 2020
FY2020 Jan 31, 2020 $346.77M Sep 23, 2020
FY2020 Oct 31, 2019 $314.77M Sep 23, 2020
FY2020 Jul 31, 2019 $299.88M Sep 23, 2020

Revenue (Net Sales)

Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.

Fiscal Year Period End Value Filed
FY2017 Jul 31, 2017 $226.10M Sep 18, 2017
FY2017 Apr 30, 2017 $191.76M Sep 18, 2017
FY2017 Jan 31, 2017 $182.20M Sep 18, 2017
FY2017 Oct 31, 2016 $166.81M Sep 18, 2017
FY2017 Jul 31, 2016 $139.79M Sep 18, 2017
FY2017 Apr 30, 2016 $114.69M Sep 18, 2017
FY2017 Jan 31, 2016 $102.70M Sep 18, 2017
FY2017 Oct 31, 2015 $87.76M Sep 18, 2017
FY2017 Jul 31, 2015 $241.43M Sep 18, 2017

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Jul 31, 2025 $188.37M Sep 24, 2025
FY2025 Jul 31, 2024 ($124.78M) Sep 24, 2025
FY2025 Jul 31, 2023 ($254.56M) Sep 24, 2025
FY2024 Jul 31, 2022 ($798.95M) Sep 19, 2024
FY2023 Jul 31, 2021 ($1.04B) Sep 21, 2023
FY2020 Jul 31, 2020 ($185.35M) Sep 23, 2020
FY2020 Apr 30, 2020 ($240.67M) Sep 23, 2020
FY2020 Jan 31, 2020 ($217.56M) Sep 23, 2020
FY2020 Oct 31, 2019 ($229.30M) Sep 23, 2020
FY2020 Jul 31, 2019 ($194.34M) Sep 23, 2020

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Jul 31, 2025 $172.54M Sep 24, 2025
FY2025 Jul 31, 2024 $7.56M Sep 24, 2025
FY2025 Jul 31, 2023 ($207.15M) Sep 24, 2025
FY2024 Jul 31, 2022 ($458.85M) Sep 19, 2024
FY2023 Jul 31, 2021 ($662.11M) Sep 21, 2023
FY2020 Jul 31, 2020 ($171.35M) Sep 23, 2020
FY2020 Apr 30, 2020 ($230.17M) Sep 23, 2020
FY2020 Jan 31, 2020 ($207.06M) Sep 23, 2020
FY2020 Oct 31, 2019 ($220.34M) Sep 23, 2020
FY2020 Jul 31, 2019 ($182.52M) Sep 23, 2020

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Jul 31, 2025 $3.28B Sep 24, 2025
FY2025 Jul 31, 2024 $2.14B Sep 24, 2025
FY2024 Jul 31, 2023 $2.53B Sep 19, 2024
FY2023 Jul 31, 2022 $2.37B Sep 21, 2023
FY2022 Jul 31, 2021 $2.28B Sep 21, 2022
FY2021 Jul 31, 2020 $1.77B Sep 21, 2021
FY2020 Jul 31, 2019 $1.79B Sep 23, 2020
FY2019 Jul 31, 2018 $1.60B Sep 24, 2019
FY2018 Jul 31, 2017 $738.21M Sep 24, 2018
FY2017 Jul 31, 2016 $399.09M Sep 18, 2017

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Jul 31, 2025 $3.98B Sep 24, 2025
FY2025 Jul 31, 2024 $2.87B Sep 24, 2025
FY2024 Jul 31, 2023 $3.23B Sep 19, 2024
FY2023 Jul 31, 2022 $3.17B Sep 21, 2023
FY2022 Jul 31, 2021 $3.29B Sep 21, 2022
FY2021 Jul 31, 2020 $2.04B Sep 21, 2021
FY2020 Jul 31, 2019 $1.60B Sep 23, 2020
FY2019 Jul 31, 2018 $1.27B Sep 24, 2019
FY2018 Jul 31, 2017 $521.15M Sep 24, 2018
FY2017 Jul 31, 2016 $465.02M Sep 18, 2017

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Jul 31, 2025 ($694.52M) Sep 24, 2025
FY2025 Jul 31, 2024 ($728.15M) Sep 24, 2025
FY2025 Jul 31, 2023 ($707.42M) Sep 24, 2025
FY2025 Jul 31, 2022 ($800.50M) Sep 24, 2025
FY2024 Jul 31, 2021 ($1.02B) Sep 19, 2024
FY2023 Jul 31, 2020 ($282.58M) Sep 21, 2023
FY2022 Jul 31, 2019 $186.89M Sep 21, 2022
FY2021 Jul 31, 2018 $326.78M Sep 21, 2021
FY2020 Jul 31, 2017 $217.06M Sep 23, 2020
FY2019 Jul 31, 2016 ($285.83M) Sep 24, 2019

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Jul 31, 2025 0 Sep 24, 2025
FY2025 Jul 31, 2024 0 Sep 24, 2025
FY2025 Jul 31, 2023 (1) Sep 24, 2025
FY2024 Jul 31, 2022 (3) Sep 19, 2024
FY2023 Jul 31, 2021 (5) Sep 21, 2023
FY2022 Jul 31, 2020 (4) Sep 21, 2022

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Jul 31, 2025 0 Sep 24, 2025
FY2025 Jul 31, 2024 0 Sep 24, 2025
FY2025 Jul 31, 2023 (1) Sep 24, 2025
FY2024 Jul 31, 2022 (3) Sep 19, 2024
FY2023 Jul 31, 2021 (5) Sep 21, 2023
FY2022 Jul 31, 2020 (4) Sep 21, 2022

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Jul 31, 2025 $769.50M Sep 24, 2025
FY2025 Jul 31, 2024 $655.27M Sep 24, 2025
FY2025 Jul 31, 2023 $512.93M Sep 24, 2025
FY2024 Jul 31, 2022 $402.85M Sep 19, 2024
FY2023 Jul 31, 2021 $285.72M Sep 21, 2023
FY2022 Jul 31, 2020 $318.74M Sep 21, 2022
FY2021 Jul 31, 2019 $396.68M Sep 21, 2021
FY2020 Jul 31, 2018 $305.98M Sep 23, 2020
FY2019 Jul 31, 2017 $138.36M Sep 24, 2019
FY2018 Jul 31, 2016 $99.21M Sep 24, 2018